
FTC Launches Investigation into IML’s Business Opportunity
Agency seeks documents from former instructor and salesperson.
In January 2013, another class-action lawsuit was filed against Pfizer regarding its marketing of Zoloft. This time, the allegation is that the drug label and marketing materials do not mention the numerous clinical trials in which Zoloft was shown to be no more effective in treating depression than placebo. Instead, Pfizer’s consumers are given the impression that Zoloft is very effective for treating depression. (Plumlee v. Pfizer, Inc., Case No. 13-cv-00414, N.D. Cal.)
Agency seeks documents from former instructor and salesperson.
Recyclable claims for products that aren’t actually being recycled need to stop.
Is this company using unapproved drug claims to market its probiotic supplement?
Julie Creswell, The New York Times
While ads suggest that feature is widely available, rollout is still in progress.